AVR - Wutah pendapatan taun lumaku Anteris Technologies Global

Logo grafis Anteris Technologies (AVR)

Anteris Technologies Global management is currently undergoing an operational adjustment phase ahead of FDA validation verdicts for its prosthetics. This trailing twelve-month revenue chart visualizes this trend, where 8.90 represents the latest metric reading. Anteris Technologies Global relies on its unique DurAVR bioprosthesis with significant pricing power, while production depends on the complex manual labor of elite specialists due to limited tissue robotization.

AVR Wutah dodolan YoY (TTM) Anteris Technologies Global (23.11.2025 - 18.11.2026)

Ringkesan rincian data analitis Anteris Technologies (AVR)

Analisis kabeh metrik perusahaan:Anteris Technologies (AVR)
Barang unggulan anteristech.com

This indicator determines the investment stability of Anteris Technologies Global (AVR) by measuring the percentage deviation of the rolling annual revenue from the figures of the same period last year to neutralize seasonality. By analyzing this 12-month YoY sales growth chart, an investor can identify the business expansion vector, which for Anteris Technologies Global (AVR) is constrained by lengthy FDA certifications and the specific nature of integrating patented heart valves into surgical practice.